Senate introduces bill requiring price disclosures on ads for prescription drugs
Sens. Dick Durbin, D-Ill., and Chuck Grassley, R-Iowa, Jan. 23 introduced the Drug-price Transparency for Consumers Act, legislation supported by the AHA that would require price disclosures on advertisements for prescription drugs. The bill would help ensure that consumers are able to make more informed decisions on prescription drugs.
Related News Articles
Headline
The 5th U.S. Circuit Court of Appeals Aug. 11 ruled to vacate certain regulations implementing how the No Surprises Act qualifying payment amount is calculated…
Headline
Update: The Senate passed the continuing resolution Aug. 8 by a vote of 90-6 and one present vote. The Senate is expected to vote this week on its own…
Headline
The AHA July 27 expressed support for the National Nursing Workforce Center Act of 2025 (S. 1482), legislation that would establish state-based nursing…
Headline
House passes CR to fund government through Dec. 4 and budget resolution for next reconciliation bill
The House July 21 passed a continuing resolution that would fund the government through Dec. 4 by a 220-205 vote. The CR does not include extensions of key…
Headline
The AHA provided comments July 21 to the Senate Committee on Health, Education, Labor and Pensions on price transparency, nursing workforce and rural…
Headline
The Centers for Medicare & Medicaid Services July 16 released draft guidance for the 2028 cycle of negotiations under the Medicare Drug Price Negotiation…